Billionaire activist investor Jeff Smith remains bullish on Kenvue (KVUE) despite the stock plunging roughly 28% year-to-date (YTD) amid controversy surrounding its Tylenol brand. Smith's enthusiasm stems from rapid management changes he helped orchestrate. Former CEO Thibaut Mongon was ousted in July and replaced by interim chief Kirk Perry, while Amit Banat took over as CFO in May.
Smith noted he would have been "really happy" a year ago if told these leadership transitions could happen so quickly, and he sees improvement in several of Kenvue's brands and business lines.
